OVID · Ovid Therapeutics Inc.
AI read · Neutral
The AI's read
The supplied filing points to a separate press release but includes no figures or business details. That leaves no stated change to assess for Ovid.
Ovid Therapeutics shared its third quarter 2026 sales and profit results with the SEC.
Neutral
Ovid filed notice that it issued business updates and third-quarter results. The filing gives no figures or update details, so it does not show a change in Ovid's outlook.
Get alerts for OVID
Follow Ovid Therapeutics Inc. (OVID) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for OVIDFree on the App Store and Google Play, or on the web.